ENTBF (Entheon Biomedical) Beginning Cash Position: $0.24 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Entheon Biomedical Beginning Cash Position?

Entheon Biomedical ENTBF Beginning Cash Position is $0.24 Mil as of Feb. 2026. The stock has 2 warning signs investors should review.

Entheon Biomedical's Beginning Cash Position for the quarter that ended in Feb. 2026 was $0.24 Mil.

Entheon Biomedical's quarterly Beginning Cash Position declined from Aug. 2025 ($0.30 Mil) to Nov. 2025 ($0.27 Mil) and declined from Nov. 2025 ($0.27 Mil) to Feb. 2026 ($0.24 Mil).

Entheon Biomedical's annual Beginning Cash Position declined from Nov. 2023 ($0.50 Mil) to Nov. 2024 ($0.25 Mil) and declined from Nov. 2024 ($0.25 Mil) to Nov. 2025 ($0.10 Mil).

Entheon Biomedical Beginning Cash Position Related Terms

Entheon Biomedical Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Entheon Biomedical's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical Beginning Cash Position Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23 Nov24 Nov25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only 2.22 1.52 0.50 0.25 0.10

Entheon Biomedical Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.38 0.30 0.27 0.24

Entheon Biomedical Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.24 Mil mean?
Entheon Biomedical (ENTBF) has a Beginning Cash Position of $0.24 Mil as of Feb. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Entheon Biomedical and its competitors.
Is Entheon Biomedical's Beginning Cash Position too high?
Entheon Biomedical's current Beginning Cash Position is $0.24 Mil.
How does Entheon Biomedical's Beginning Cash Position compare to VRTX and REGN?
Entheon Biomedical's Beginning Cash Position of $0.24 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Entheon Biomedical and its competitors. Entheon Biomedical's current Beginning Cash Position is $0.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entheon Biomedical stock overvalued right now?
Entheon Biomedical (ENTBF) has a current Beginning Cash Position of $0.24 Mil. The current Beginning Cash Position is $0.24 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Entheon Biomedical (ENTBF), the current Beginning Cash Position is $0.24 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entheon Biomedical Business Description

Other Exchanges 1XU:GermanyENBI.X:Canada
Address 999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company focused on treating addiction and substance use disorders.